Biowisdom Selected by AstraZeneca to Create Custom Vocabulary Assertional Meta-Data in Effort to Improve Drug Safety Assessments
Tuesday, April 7th, 2009BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announced that AstraZeneca, one of the world’s leading pharmaceutical companies, has selected them to apply the Sofia platform to generate a rich vocabulary and assertional meta-data from thousands of AstraZeneca-owned toxicology reports.
Read more about Biowisdom Selected by AstraZeneca to Create Custom Vocabulary Assertional... »